Clinical Trial Update: CVI Drug Coated Balloon First In Human Trial [NA]

View source ↗

Summary

First-in-human trial of the CVI Drug Coated Balloon conducted by Spectranetics for Peripheral Arterial Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• CVI Drug Coated Balloon

Snippet

Sponsor: Spectranetics Corporation | Conditions: Peripheral Arterial Disease | NA | Status: COMPLETED